Financial
Latest full-year results from official filings.
FY2025 revenue $4.66bn (+15.6%); operating margin 19.6%; net income $836.3m.
Cash $2.00bn; debt $1.24bn.
- Official results release · Dexcom · 31 Dec 2025
Dexcom: risk summary
Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Adverse media
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Oct 2025: A proposed consumer class action filed in the US District Court for the Central District of California alleges Dexcom marketed its G7 monitor as superior while selling devices prone to alert failures; the claims are unproven and no company response was reported.
- Dexcom faces class action suit related to G7 CGM · MassDevice · 17 Oct 2025
Cyber & information governance
Data breaches, cyber incidents, regulator action and assurance status.
Oct 2026: Dexcom disclosed a cyber incident after targeted voice-phishing in which unauthorised parties accessed limited information from internal documents; it says products and operations were unaffected and the incident was contained. NHS DSPT status not yet checked.
- Dexcom statement on cybersecurity incident · Dexcom · 10 Oct 2026
Regulatory & clinical safety
Recalls, safety notices, regulator action and clinical safety concerns.
Sep 2025: FDA classed Dexcom's correction of its G7 and ONE+ apps (missed 'Sensor Failed' alerts) as the most serious recall type; no injuries were reported. In Mar 2025 an FDA warning letter said unapproved G6/G7 sensor changes amounted to misbranding.
- Continuous Glucose Monitor Apps Correction: Dexcom, Inc. Issues Correction for G7 Apps and ONE+ Apps · US FDA · 15 Sept 2025
- FDA says changes in Dexcom G6, G7 sensors constitute misbranding · BioWorld · 26 Mar 2025
Contract performance
Contract delivery, go-lives, terminations and disputes.
No contract terminations, disputes or significant NHS contract news involving Dexcom found in HSH's search of the last 24 months.